IQVIA Holdings, Inc. (IQV): Price and Financial Metrics


IQVIA Holdings, Inc. (IQV)

Today's Latest Price: $167.47 USD

1.93 (-1.14%)

Updated Oct 23 7:00pm

Add IQV to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 58 in Medical - Diagnostics/Research

See all "A" rated Strong Buy stocks

IQV Stock Summary

  • With a market capitalization of $32,372,610,996, Iqvia Holdings Inc has a greater market value than 93.83% of US stocks.
  • IQV's current price/earnings ratio is 245.25, which is higher than 96.98% of US stocks with positive earnings.
  • The volatility of Iqvia Holdings Inc's share price is greater than that of only 19.39% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to Iqvia Holdings Inc, a group of peers worth examining would be RSG, VRSK, LVS, NDAQ, and LH.
  • Visit IQV's SEC page to see the company's official filings. To visit the company's web site, go to www.iqvia.com.

IQV Stock Price Chart Interactive Chart >

Price chart for IQV

IQV Price/Volume Stats

Current price $167.47 52-week high $176.00
Prev. close $169.40 52-week low $81.79
Day low $166.53 Volume 760,587
Day high $170.77 Avg. volume 1,384,523
50-day MA $160.91 Dividend yield N/A
200-day MA $146.45 Market Cap 32.03B

IQVIA Holdings, Inc. (IQV) Company Bio


IQVIA provides biopharmaceutical development services and commercial outsourcing services in the Americas, Europe, Africa, and the Asia-Pacific. It operates through two segments, Product Development and Integrated Healthcare Services. The company was founded in 1982 and is based in Durham, North Carolina.

IQV Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$167.47$98.18 -42%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Iqvia Holdings Inc. To summarize, we found that Iqvia Holdings Inc ranked in the 34th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. The most interesting components of our discounted cash flow analysis for Iqvia Holdings Inc ended up being:

  • The company's compound free cash flow growth rate over the past 5.45 years comes in at 0.21%; that's greater than 60.17% of US stocks we're applying DCF forecasting to.
  • Relative to other stocks in its sector (Healthcare), Iqvia Holdings Inc has a reliance on debt greater than 67.67% of them.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-43%
1%-43%
2%-42%
3%-41%
4%-41%
5%-40%

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as IQV, try MD, QDEL, GSK, HZNP, and OSMT.


IQV Latest News Stream


Event/Time News Detail
Loading, please wait...

IQV Latest Social Stream


Loading social stream, please wait...

View Full IQV Social Stream

Latest IQV News From Around the Web

Below are the latest news stories about Iqvia Holdings Inc that investors may wish to consider to help them evaluate IQV as an investment opportunity.

Insiders Roundup: Tetraphase Pharmaceuticals, Bank of America

Largest insider trades of the week Continue reading...

Yahoo | July 31, 2020

IQV vs. SSTI: Which Stock Should Value Investors Buy Now?

IQV vs. SSTI: Which Stock Is the Better Value Option?

Yahoo | July 30, 2020

IQVIA Launches OCE Optimizer to Help Intelligently Plan HCP Engagements and Maximize Commercial Effectiveness

IQVIA™ (NYSE: IQV) today introduced OCE Optimizer, an innovative solution that empowers life sciences companies to plan and refine marketing engagements with healthcare providers (HCPs) on demand. OCE Optimizer extends IQVIA’s Orchestrated Customer Engagement solution by intelligently allocating commercial resources and interaction channels for more effective connections.

Yahoo | July 29, 2020

Earnings Update: Here's Why Analysts Just Lifted Their IQVIA Holdings Inc. (NYSE:IQV) Price Target To US$179

Investors in IQVIA Holdings Inc. (NYSE:IQV) had a good week, as its shares rose 2.5% to close at US$158 following the...

Yahoo | July 25, 2020

IQVIA Human Data Science Research Collaborative Initiative Waives Data Access Fees for Academic Researchers

IQVIA™ (NYSE: IQV) announced a new Human Data Science Research Collaborative initiative that is waiving licensing and access fees for approved academic researchers around the world to use two IQVIA data technology platforms and analytics from multiple countries to accelerate research addressing challenges and opportunities for health systems in the COVID-19 era.

Yahoo | July 23, 2020

Read More 'IQV' Stories Here

IQV Price Returns

1-mo 13.10%
3-mo 6.07%
6-mo 26.99%
1-year 13.53%
3-year 65.00%
5-year 142.22%
YTD 8.39%
2019 33.00%
2018 18.66%
2017 28.73%
2016 10.76%
2015 16.63%

Continue Researching IQV

Here are a few links from around the web to help you further your research on Iqvia Holdings Inc's stock as an investment opportunity:

Iqvia Holdings Inc (IQV) Stock Price | Nasdaq
Iqvia Holdings Inc (IQV) Stock Quote, History and News - Yahoo Finance
Iqvia Holdings Inc (IQV) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.77 seconds.